Healthcare >> CEO Interviews >> March 12, 2018
Eduardo Bravo is Managing Director and Chief Executive Officer of TiGenix. Prior to joining TiGenix in 2005, Mr. Bravo held several senior management and commercial positions at Sanofi-Aventis and SmithKline Beecham, lastly as Vice President for Latin America for Sanofi-Aventis. He holds a degree in business administration and an MBA from INSEAD. Mr. Bravo is President of the EBE — European Biopharmaceutical Enterprises — board of directors and member of the Executive Committee of ARM — Alliance for Regenerative Medicine. Profile
TWST: How would you characterize TiGenix? Also, if you could, briefly characterize in a distilled way what you believe your core technology to be.
Mr. Bravo: TiGenix is a